Delcath Systems, Inc. (DCTH): Operating Cash Flow
$22.52M
Year ended 2025-12-31
$19.59M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $22.52M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$18.68M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$31.25M | n/m | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | -$24.95M | n/m | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | -$22.60M | n/m | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | -$22.87M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$23.69M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$14.73M | n/m | 2020-03-25, From 2018-01-01 |
| 2017-12-31 | -$15.40M | n/m | 2019-06-14, From 2017-01-01 |
| 2016-12-31 | -$14.21M | n/m | 2018-03-16, From 2016-01-01 |
| 2015-12-31 | -$16.42M | n/m | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | -$15.55M | n/m | 2016-03-18, From 2014-01-01 |
| 2013-12-31 | -$34.10M | n/m | 2014-03-12, From 2013-01-01 |
| 2012-12-31 | -$50.01M | n/m | 2014-03-12, From 2012-01-01 |
| 2011-12-31 | -$37.37M | n/m | 2014-03-12, From 2011-01-01 |
| 2010-12-31 | -$24.08M | n/m | 2013-03-13, From 2010-01-01 |
| 2009-12-31 | -$10.46M | n/a | 2012-03-06, From 2009-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $22.52M | n/m |
| Iradimed Corp (IRMD) | 2025-12-31 | $24.95M | -2.6% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | -$28.22M | n/m |
| Pulmonx Corp (LUNG) | 2025-12-31 | -$32.38M | n/m |
| PRO DEX Inc (PDEX) | 2026-06-30 | $7.24M | n/m |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | -$29.69M | n/m |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | -$81.70M | n/m |
| NeuroPace Inc (NPCE) | 2025-12-31 | -$11.01M | n/m |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | -$50.92M | n/m |
Compare DCTH, IRMD, TELA, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗